Micropulse laser in patients with refractory and treatment-naïve center-involved diabetic macular edema: short terms visual and anatomic outcomes.

Diego Alejandro Valera-Cornejo Marlon Rafael Garcia-RoaJaime Quiroz-MendozaAlejandro Arias-GómezPaulina Ramírez-NeriaYolanda Villalpando-GómezVeronica Romero-MoralesRenata García-Franco

Published in: Therapeutic advances in ophthalmology (2021)

We concluded that micropulse 577nm laser therapy maintained the visual acuity and macular thickness at 3 months in both treatment-naïve and refractory DME.

Keyphrases

optical coherence tomography
type diabetes
metabolic syndrome
skeletal muscle
mass spectrometry
insulin resistance